Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY:ASX)

24.05 +0.31 (+1.31%)
Streaming Delayed Price Updated: 9:54 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ASE Technology Holding Co., Ltd. American Depositary Shares (each representing

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
ATHA Energy Announces Option Agreements With Terra Uranium for Spire, Horizon, and Pasfield Projects
From ATHA Energy Corp.
Via GlobeNewswire
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for October 10th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Novo Resources to Present at the Battery and Precious Metals Virtual Investor Conference October
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Life360 Set to Join Russell 2000® and 3000® Indexes
From Life360, Inc.
Via GlobeNewswire
News headline image
Clean Energy Metals Virtual Investor Conference Agenda Announced for August 29th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Global Uranium and Enrichment to Present at the OTCQB Venture Virtual Investor Conference August 1st
Global Uranium invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Alterity Therapeutics to Present at MST Financial Webinar
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Discover the Hidden Gem in Chip Manufacturing Stocks
ASE Technology Holding Co. Ltd. (NYSE: ASX) is a Taiwan-based semiconductor manufacturing company you’ve probably never heard of. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
ISE Labs Expands Capabilities, Doubles Lab Space with Opening of Second Silicon Valley Location
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
News headline image
OTC Markets Group Welcomes Sovereign Metals Limited to OTCQX
From OTC Markets
Via GlobeNewswire
News headline image
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
From CSL Behring
Via GlobeNewswire
News headline image
ASE Holdings Hosts Annual Supplier Day to Recognize Outstanding Suppliers of 2023
From ASE Technology Holding Co., Ltd.
Via Business Wire
News headline image
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Small-Cap Growth Virtual Investor Conference Agenda Announced for June 13th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
ASE Introduces powerSiP™ for Transformative Power Delivery That Increases Power Efficiencies by 50% in AI and Data Center Applications
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
News headline image
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access
The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes. 
From MatrixCare
Via GlobeNewswire
News headline image
OTC Markets Group Welcomes Neometals Ltd. to OTCQX
From OTC Markets
Via GlobeNewswire
News headline image
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
News headline image
OTCQX Best 50 Virtual Investor Conference Agenda Announced for April 18th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.